Barrington Research Raises Huron Consulting Group (NASDAQ:HURN) Price Target to $142.00

Huron Consulting Group (NASDAQ:HURN) had its price target lifted by equities researchers at Barrington Research from $137.00 to $142.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an “outperform” rating on the business services provider’s stock. Barrington Research’s price objective indicates a potential upside of 18.02% from the stock’s current price.

A number of other research firms have also recently weighed in on HURN. Benchmark reissued a “buy” rating and issued a $140.00 target price on shares of Huron Consulting Group in a research note on Wednesday, October 30th. StockNews.com upgraded Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $133.00.

Huron Consulting Group Stock Up 1.8 %

HURN stock opened at $120.32 on Monday. Huron Consulting Group has a twelve month low of $84.26 and a twelve month high of $120.41. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The company has a market cap of $2.13 billion, a PE ratio of 26.16 and a beta of 0.60. The business’s 50-day simple moving average is $108.09 and its 200 day simple moving average is $101.37.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings data on Tuesday, October 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.11. The business had revenue of $370.00 million for the quarter, compared to analysts’ expectations of $377.63 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. Huron Consulting Group’s quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.39 earnings per share. On average, research analysts anticipate that Huron Consulting Group will post 6.11 earnings per share for the current year.

Insider Transactions at Huron Consulting Group

In related news, CEO C. Mark Hussey sold 4,000 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $103.13, for a total transaction of $412,520.00. Following the sale, the chief executive officer now directly owns 81,081 shares in the company, valued at $8,361,883.53. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO C. Mark Hussey sold 4,000 shares of the stock in a transaction on Monday, August 12th. The stock was sold at an average price of $103.13, for a total transaction of $412,520.00. Following the sale, the chief executive officer now owns 81,081 shares in the company, valued at approximately $8,361,883.53. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $109.48, for a total value of $114,078.16. Following the completion of the transaction, the director now directly owns 29,882 shares of the company’s stock, valued at $3,271,481.36. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,390 shares of company stock valued at $890,312. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of Huron Consulting Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Chartwell Investment Partners LLC lifted its holdings in Huron Consulting Group by 43.3% during the 3rd quarter. Chartwell Investment Partners LLC now owns 8,196 shares of the business services provider’s stock worth $891,000 after buying an additional 2,477 shares in the last quarter. Assetmark Inc. lifted its stake in shares of Huron Consulting Group by 7.0% during the third quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after acquiring an additional 90 shares during the period. Olympiad Research LP bought a new position in Huron Consulting Group in the third quarter valued at about $299,000. Principal Financial Group Inc. increased its position in Huron Consulting Group by 4.7% in the third quarter. Principal Financial Group Inc. now owns 380,024 shares of the business services provider’s stock worth $41,308,000 after purchasing an additional 17,146 shares during the period. Finally, Asset Management One Co. Ltd. raised its holdings in Huron Consulting Group by 2.5% during the 3rd quarter. Asset Management One Co. Ltd. now owns 58,259 shares of the business services provider’s stock worth $6,333,000 after purchasing an additional 1,398 shares during the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.